Physician profile
Mark G Strauss
NPI 1629053186
$1,119.55
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $505 · 2021: $198 · 2022: $11.71 · 2023: $47.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $47.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $47.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $212.84 | 2019-2022 | |
| Pfizer INC. | $131.00 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $110.84 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $84.76 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $74.67 | 2019-2020 | |
| Radius Health, INC. | $60.80 | 2019-2023 | Tymlos |
| Astrazeneca Pharmaceuticals Lp | $57.92 | 2019-2020 | |
| Novo Nordisk INC | $53.93 | 2019-2021 | |
| Esperion Therapeutics, INC. | $52.38 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $50.65 | 2019-2020 | |
| Amarin Pharma, INC. | $47.04 | 2019-2021 | |
| Boston Scientific Corporation | $45.18 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.87 | 2019-2020 | |
| Amgen INC. | $27.11 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $26.39 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $16.92 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.21 | 2019 | |
| Astellas Pharma US INC | $12.21 | 2019 | |
| Genentech USA, INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Strauss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.